Envair Electrodyne shareholding pattern

ENVAIREL

85.49

4.07 (5.00%)
Last updated on 20 May, 2026 | 15:27 IST
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Envair Electrodyne Shareholding Pattern

  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2025-26
  • 2026-27
  • 2023-24
  • 2024-25
Total Promoters
Segment
Percent

Total Promoters

53.22%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0%

Domestic Institutional Investors

0%

Retail

46.78%

Others

0%

Total Promoters
MAR '22
53.22%
JUN '22
53.22%
SEP '22
53.22%
DEC '22
53.22%

Summary

Envair Electrodyne share holding pattern reports the following shareholding: Envair Electrodyne Total Promoters is at 57.52%, Mutual Fund at 0.00%, Insurance at 0.00%, Foreign Institutional Investors at 0.00%, Domestic Institutional Investors at 0.00%, and Retail at 42.48%. This breakdown provides a quick snapshot of ownership distribution for Envair Electrodyne share holding pattern in 2026-27.

Envair Electrodyne FAQs

As of 05-2026, the promoter shareholding in Envair Electrodyne stands at 57.52% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Envair Electrodyne is 0% and 0% respectively.

The retail shareholding of the Envair Electrodyne is 42.48%.

Changes in shareholding patterns of Envair Electrodyne can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Envair Electrodyne are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost